Cerebral Ischemia Combined With Amyloid Angiopathy Significantly Deteriorated Cognitive Impairment via Angiotensin AT1 Receptor in a Mouse Model of Alzheimer's Disease

被引：0
|
作者：
Nakagawa, Takashi [1 ]
Hasegawa, Yu [1 ]
Mitsuyama, Shokei K. [1 ]
机构：
[1] Kumamoto Univ, Kumamoto, Japan
来源：
STROKE | 2016年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
TMP114
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke
    Whitehead, Shawn N.
    Massonic, Erika
    Cheng, Guanliang
    Hachinski, Vladimir C.
    Cimino, Mauro
    Balduini, Walter
    Cechetto, David F.
    BRAIN RESEARCH, 2010, 1366 : 246 - 256
  • [32] Caveolin-1 and-2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease
    van Helmond, Z. K.
    Miners, J. S.
    Bednall, E.
    Chalmers, K. A.
    Zhang, Y.
    Wilcock, G. K.
    Love, S.
    Kehoe, P. G.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2007, 33 (03) : 317 - 327
  • [33] β-Lapachone attenuates cognitive impairment and neuroinflammation in beta-amyloid induced mouse model of Alzheimer's disease
    Mokarizadeh, Narmin
    Karimi, Pouran
    Erfani, Marjan
    Sadigh-Eteghad, Saeed
    Maroufi, Nazila Fathi
    Rashtchizadeh, Nadereh
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
  • [34] Cognitive impairment depends on ApoE and ACT-catalyzed amyloid formation in a mouse model of Alzheimer's disease
    Nilsson, LNG
    Arendash, G
    Low, M
    Costa, D
    Roijani, A
    Potter, H
    Wu, X
    Bales, R
    Paul, SM
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S199 - S199
  • [35] Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease
    Brueckmann, Sascha
    Brenn, Anja
    Grube, Markus
    Niedrig, Katharina
    Holtfreter, Silva
    Halbach, Oliver von Bohlen Und
    Groschup, Martin
    Keller, Markus
    Vogelgesang, Silke
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (06) : 656 - 667
  • [36] Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease
    Ye, Chenghui
    Liang, Yubin
    Chen, Ying
    Xiong, Yu
    She, Yingfang
    Zhong, Xiaochun
    Chen, Hongda
    Huang, Min
    CELLS, 2021, 10 (05)
  • [37] Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease
    Li, Hui-Qin
    Ip, Siu-Po
    Yuan, Qiu-Ju
    Zheng, Guo-Qing
    Tsim, Karl K. W.
    Dong, Tina T. X.
    Lin, Ge
    Han, Yifan
    Liu, Yue
    Xian, Yan-Fang
    Lin, Zhi-Xiu
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 82 : 264 - 278
  • [38] SPON1 Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer's Disease Mouse Model
    Park, Soo Yong
    Kang, Joo Yeong
    Lee, Taehee
    Nam, Donggyu
    Jeon, Chang-Jin
    Kim, Jeong Beom
    CELLS, 2020, 9 (05)
  • [39] Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease
    Uekawa, Ken
    Hasegawa, Yu
    Senju, Satoru
    Nakagata, Naomi
    Ma, Mingjie
    Nakagawa, Takashi
    Koibuchi, Nobutaka
    Kim-Mitsuyama, Shokei
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (01) : 127 - 133
  • [40] PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease
    Zhen, Gehua
    Kim, Yun Tai
    Li, Rung-chi
    Yocum, Jennifer
    Kapoor, Nidhi
    Langer, John
    Dobrowolski, Peter
    Maruyama, Takayuki
    Narumiya, Shuh
    Dore, Sylvain
    NEUROBIOLOGY OF AGING, 2012, 33 (09) : 2215 - 2219
12345